David Hung

(Dr. David Hung M.D.)

Currently holds positions in Establishment Labs Holdings Inc and Novocure Ltd

Positions

Position Company Period
Independent Director Establishment Labs Holdings Inc Jan. 1, 2016 -
Independent Director Novocure Ltd May 31, 2018 -
Chief Executive Officer, Director Axovant Gene Therapies Ltd April 7, 2017 - Feb. 12, 2018
President, Chief Executive Officer, Director Medivation Inc Dec. 17, 2004 - Sept. 28, 2016
David Hung's trades of Nuvation Bio Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-08 2025-04-07
B Purchase
300,000 +0.5%
1.63
USD 487,500 		300,000 +0.5% 1.63 USD 487,500
2025-04-08 2025-04-04
B Purchase
200,000 +0.3%
1.66
USD 332,720 		200,000 +0.3% 1.66 USD 332,720
2009-09-10 2009-09-10
S Sale
20,200 -100.0%
4.18
USD 84,436 		20,200 -100.0% 4.18 USD 84,436
2009-08-27 2009-08-26
S Sale
6,800 -25.2%
1.53
USD 10,404 		6,800 -25.2% 1.53 USD 10,404
2009-08-27 2009-08-25
S Sale
20,000 -42.6%
1.43
USD 28,600 		20,000 -42.6% 1.43 USD 28,600
2009-08-21 2009-08-20
S Sale
5 -0.0%
1.60
USD 8 		5 -0.0% 1.60 USD 8
// ... existing code ... // ... rest of the file ...